Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.5000
+0.0400 (8.70%)
Jul 24, 2026, 4:23 PM GMT
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 16.41 million as of July 24, 2026. Its market cap has increased by 85.23% in one year.
Market Cap
16.41M
Enterprise Value
15.22M
Revenue
1.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
ChartMarket Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 16.41M, a decrease of -83.18%. That is a compound annual growth rate of -32.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 16.41M | -43.39% |
| Dec 31, 2025 | 28.99M | 308.04% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sareum Holdings | 30.48M |
| SkinBioTherapeutics | 30.45M |
| ImmuPharma | 28.08M |
| Arecor Therapeutics | 23.98M |
| IXICO | 18.53M |
| Fusion Antibodies | 13.44M |
| Palatin Technologies | 12.78M |
| Genflow Biosciences | 10.76M |